Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 35521 to 130 of 130 entries
Sorted by: Best Match Show Resources per page
A closer look at heart failure in patients with concurrent diabetes mellitus using glucose lowering drugs.

Expert review of clinical pharmacology

Shah SR, Iqbal SM, Alweis R, Roark S.
PMID: 30488734
Expert Rev Clin Pharmacol. 2019 Jan;12(1):45-52. doi: 10.1080/17512433.2019.1552830. Epub 2018 Dec 03.

INTRODUCTION: Type 2 diabetes (T2D) is an independent risk factor for heart failure (HF). With concomitant T2D and HF, recent data suggests an incremental risk of cardiovascular death and hospitalization for HF, as compared to patients with HF without...

Cite
Shah SR, Iqbal SM, Alweis R, et al. A closer look at heart failure in patients with concurrent diabetes mellitus using glucose lowering drugs. Expert Rev Clin Pharmacol. 2018;12(1):45-52doi: 10.1080/17512433.2019.1552830.
Shah, S. R., Iqbal, S. M., Alweis, R., & Roark, S. (2019). A closer look at heart failure in patients with concurrent diabetes mellitus using glucose lowering drugs. Expert review of clinical pharmacology, 12(1), 45-52. https://doi.org/10.1080/17512433.2019.1552830
Shah, Syed Raza, et al. "A closer look at heart failure in patients with concurrent diabetes mellitus using glucose lowering drugs." Expert review of clinical pharmacology vol. 12,1 (2019): 45-52. doi: https://doi.org/10.1080/17512433.2019.1552830
Shah SR, Iqbal SM, Alweis R, Roark S. A closer look at heart failure in patients with concurrent diabetes mellitus using glucose lowering drugs. Expert Rev Clin Pharmacol. 2019 Jan;12(1):45-52. doi: 10.1080/17512433.2019.1552830. Epub 2018 Dec 03. PMID: 30488734.
Copy Download .nbib Format: NLM
Changing QRS duration and morphology with A-paced and A-sensed rhythm in postcardiac resynchronization therapy (CRT) patients.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc

Deshpande SA, Udyavar A.
PMID: 31557359
Ann Noninvasive Electrocardiol. 2020 May;25(3):e12703. doi: 10.1111/anec.12703. Epub 2019 Sep 26.

Meticulous interpretation of the ECGs of patients with cardiac resynchronization defibrillator therapy (CRT-D) device is important to ensure optimal synchronization of both the chambers. We present the ECGs of such a patient who was noted to have different morphologies...

Cite
Deshpande SA, Udyavar A. Changing QRS duration and morphology with A-paced and A-sensed rhythm in postcardiac resynchronization therapy (CRT) patients. Ann Noninvasive Electrocardiol. 2019;25(3):e12703doi: 10.1111/anec.12703.
Deshpande, S. A., & Udyavar, A. (2020). Changing QRS duration and morphology with A-paced and A-sensed rhythm in postcardiac resynchronization therapy (CRT) patients. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 25(3), e12703. https://doi.org/10.1111/anec.12703
Deshpande, Saurabh Ajit, and Udyavar, Ameya. "Changing QRS duration and morphology with A-paced and A-sensed rhythm in postcardiac resynchronization therapy (CRT) patients." Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc vol. 25,3 (2020): e12703. doi: https://doi.org/10.1111/anec.12703
Deshpande SA, Udyavar A. Changing QRS duration and morphology with A-paced and A-sensed rhythm in postcardiac resynchronization therapy (CRT) patients. Ann Noninvasive Electrocardiol. 2020 May;25(3):e12703. doi: 10.1111/anec.12703. Epub 2019 Sep 26. PMID: 31557359; PMCID: PMC7358890.
Copy Download .nbib Format: NLM
Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?.

Expert review of clinical pharmacology

Pafili K, Papanas N.
PMID: 31232616
Expert Rev Clin Pharmacol. 2019 Aug;12(8):693-695. doi: 10.1080/17512433.2019.1635453. Epub 2019 Jun 30.

No abstract available.

Cite
Pafili K, Papanas N. Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?. Expert Rev Clin Pharmacol. 2019;12(8):693-695doi: 10.1080/17512433.2019.1635453.
Pafili, K., & Papanas, N. (2019). Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?. Expert review of clinical pharmacology, 12(8), 693-695. https://doi.org/10.1080/17512433.2019.1635453
Pafili, K, and Papanas, N. "Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?." Expert review of clinical pharmacology vol. 12,8 (2019): 693-695. doi: https://doi.org/10.1080/17512433.2019.1635453
Pafili K, Papanas N. Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?. Expert Rev Clin Pharmacol. 2019 Aug;12(8):693-695. doi: 10.1080/17512433.2019.1635453. Epub 2019 Jun 30. PMID: 31232616.
Copy Download .nbib Format: NLM
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

European journal of heart failure

de Boer RA, Hulot JS, Tocchetti CG, Aboumsallem JP, Ameri P, Anker SD, Bauersachs J, Bertero E, Coats AJS, Čelutkienė J, Chioncel O, Dodion P, Eschenhagen T, Farmakis D, Bayes-Genis A, Jäger D, Jankowska EA, Kitsis RN, Konety SH, Larkin J, Lehmann L, Lenihan DJ, Maack C, Moslehi JJ, Müller OJ, Nowak-Sliwinska P, Piepoli MF, Ponikowski P, Pudil R, Rainer PP, Ruschitzka F, Sawyer D, Seferovic PM, Suter T, Thum T, van der Meer P, Van Laake LW, von Haehling S, Heymans S, Lyon AR, Backs J.
PMID: 33094495
Eur J Heart Fail. 2020 Dec;22(12):2272-2289. doi: 10.1002/ejhf.2029. Epub 2020 Nov 12.

The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback as each disease interferes with the treatment of the other. In addition to shared risk factors, a growing body of experimental and clinical evidence reveals numerous...

Cite
de Boer RA, Hulot JS, Tocchetti CG, et al. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020;22(12):2272-2289doi: 10.1002/ejhf.2029.
de Boer, R. A., Hulot, J. S., Tocchetti, C. G., Aboumsallem, J. P., Ameri, P., Anker, S. D., Bauersachs, J., Bertero, E., Coats, A. J. S., Čelutkienė, J., Chioncel, O., Dodion, P., Eschenhagen, T., Farmakis, D., Bayes-Genis, A., Jäger, D., Jankowska, E. A., Kitsis, R. N., Konety, S. H., Larkin, J., Lehmann, L., Lenihan, D. J., Maack, C., Moslehi, J. J., Müller, O. J., Nowak-Sliwinska, P., Piepoli, M. F., Ponikowski, P., Pudil, R., Rainer, P. P., Ruschitzka, F., Sawyer, D., Seferovic, P. M., Suter, T., Thum, T., van der Meer, P., Van Laake, L. W., von Haehling, S., Heymans, S., Lyon, A. R., & Backs, J. (2020). Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European journal of heart failure, 22(12), 2272-2289. https://doi.org/10.1002/ejhf.2029
de Boer, Rudolf A, et al. "Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)." European journal of heart failure vol. 22,12 (2020): 2272-2289. doi: https://doi.org/10.1002/ejhf.2029
de Boer RA, Hulot JS, Tocchetti CG, Aboumsallem JP, Ameri P, Anker SD, Bauersachs J, Bertero E, Coats AJS, Čelutkienė J, Chioncel O, Dodion P, Eschenhagen T, Farmakis D, Bayes-Genis A, Jäger D, Jankowska EA, Kitsis RN, Konety SH, Larkin J, Lehmann L, Lenihan DJ, Maack C, Moslehi JJ, Müller OJ, Nowak-Sliwinska P, Piepoli MF, Ponikowski P, Pudil R, Rainer PP, Ruschitzka F, Sawyer D, Seferovic PM, Suter T, Thum T, van der Meer P, Van Laake LW, von Haehling S, Heymans S, Lyon AR, Backs J. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020 Dec;22(12):2272-2289. doi: 10.1002/ejhf.2029. Epub 2020 Nov 12. PMID: 33094495; PMCID: PMC7894564.
Copy Download .nbib Format: NLM
[Diabetes mellitus and congestive heart failure: physiopathology and treatment].

Revue medicale suisse

De Flines J, Scheen AJ.
PMID: 16972538
Rev Med Suisse. 2006 Aug 23;2(76):1893-6, 1898-900.

Diabetes mellitus increases by 2.5 to 5 the relative risk of congestive heart failure. Besides the classical risk factors of congestive heart failure such as obesity, arterial hypertension and coronary artery disease that are frequently associated to type 2...

Cite
De Flines J, Scheen AJ. Diabète sucré et décompensation cardiaque: spécificités ethiopathogéniques et thérapeutiques. [Diabetes mellitus and congestive heart failure: physiopathology and treatment]. Rev Med Suisse. 2006;2(76):1893-6, 1898-900
De Flines, J., & Scheen, A. J. (2006). Diabète sucré et décompensation cardiaque: spécificités ethiopathogéniques et thérapeutiques. [Diabetes mellitus and congestive heart failure: physiopathology and treatment]. Revue medicale suisse, 2(76), 1893-6, 1898-900.
De Flines, J, and Scheen, A J. "Diabète sucré et décompensation cardiaque: spécificités ethiopathogéniques et thérapeutiques." [Diabetes mellitus and congestive heart failure: physiopathology and treatment]. Revue medicale suisse vol. 2,76 (2006): 1893-6, 1898-900.
De Flines J, Scheen AJ. Diabète sucré et décompensation cardiaque: spécificités ethiopathogéniques et thérapeutiques. [Diabetes mellitus and congestive heart failure: physiopathology and treatment]. Rev Med Suisse. 2006 Aug 23;2(76):1893-6, 1898-900. French. PMID: 16972538.
Copy Download .nbib Format: NLM
Sleep-Disordered Breathing in Heart Failure　- A Therapeutic Dilemma.

Circulation journal : official journal of the Japanese Circulation Society

Haruki N, Floras JS.
PMID: 28539541
Circ J. 2017 Jun 23;81(7):903-912. doi: 10.1253/circj.CJ-17-0440. Epub 2017 May 23.

Sleep-disordered breathing (SDB) occurs in approximately 50% of patients with reduced left ventricular ejection fraction receiving contemporary heart failure (HF) therapies. Obstructive (OSA) and central sleep apneas (CSA) interrupt breathing by different mechanisms but impose qualitatively similar autonomic, chemical,...

Cite
Haruki N, Floras JS. Sleep-Disordered Breathing in Heart Failure　- A Therapeutic Dilemma. Circ J. 2017;81(7):903-912doi: 10.1253/circj.CJ-17-0440.
Haruki, N., & Floras, J. S. (2017). Sleep-Disordered Breathing in Heart Failure　- A Therapeutic Dilemma. Circulation journal : official journal of the Japanese Circulation Society, 81(7), 903-912. https://doi.org/10.1253/circj.CJ-17-0440
Haruki, Nobuhiko, and Floras, John S. "Sleep-Disordered Breathing in Heart Failure　- A Therapeutic Dilemma." Circulation journal : official journal of the Japanese Circulation Society vol. 81,7 (2017): 903-912. doi: https://doi.org/10.1253/circj.CJ-17-0440
Haruki N, Floras JS. Sleep-Disordered Breathing in Heart Failure　- A Therapeutic Dilemma. Circ J. 2017 Jun 23;81(7):903-912. doi: 10.1253/circj.CJ-17-0440. Epub 2017 May 23. PMID: 28539541.
Copy Download .nbib Format: NLM
Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.

Endocrinology and metabolism clinics of North America

Jorsal A, Wiggers H, McMurray JJV.
PMID: 29407047
Endocrinol Metab Clin North Am. 2018 Mar;47(1):117-135. doi: 10.1016/j.ecl.2017.10.007. Epub 2017 Dec 08.

This article briefly discusses the epidemiology of heart failure and diabetes and summarizes the key findings from the recent cardiovascular outcome trials in patients with type 2 diabetes, with a focus on heart failure as an endpoint.

Cite
Jorsal A, Wiggers H, McMurray JJV. Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus. Endocrinol Metab Clin North Am. 2017;47(1):117-135doi: 10.1016/j.ecl.2017.10.007.
Jorsal, A., Wiggers, H., & McMurray, J. J. V. (2018). Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus. Endocrinology and metabolism clinics of North America, 47(1), 117-135. https://doi.org/10.1016/j.ecl.2017.10.007
Jorsal, Anders, et al. "Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus." Endocrinology and metabolism clinics of North America vol. 47,1 (2018): 117-135. doi: https://doi.org/10.1016/j.ecl.2017.10.007
Jorsal A, Wiggers H, McMurray JJV. Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus. Endocrinol Metab Clin North Am. 2018 Mar;47(1):117-135. doi: 10.1016/j.ecl.2017.10.007. Epub 2017 Dec 08. PMID: 29407047.
Copy Download .nbib Format: NLM
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.

Journal of the American College of Cardiology

Marwick TH, Ritchie R, Shaw JE, Kaye D.
PMID: 29348027
J Am Coll Cardiol. 2018 Jan 23;71(3):339-351. doi: 10.1016/j.jacc.2017.11.019.

Heart failure is a complex clinical syndrome, the incidence and prevalence of which is increased in diabetes mellitus, pre-diabetes, and obesity. Although this may arise from underlying coronary artery disease, it often occurs in the absence of significant major...

Cite
Marwick TH, Ritchie R, Shaw JE, et al. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. J Am Coll Cardiol. 2018;71(3):339-351doi: 10.1016/j.jacc.2017.11.019.
Marwick, T. H., Ritchie, R., Shaw, J. E., & Kaye, D. (2018). Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. Journal of the American College of Cardiology, 71(3), 339-351. https://doi.org/10.1016/j.jacc.2017.11.019
Marwick, Thomas H, et al. "Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy." Journal of the American College of Cardiology vol. 71,3 (2018): 339-351. doi: https://doi.org/10.1016/j.jacc.2017.11.019
Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. J Am Coll Cardiol. 2018 Jan 23;71(3):339-351. doi: 10.1016/j.jacc.2017.11.019. PMID: 29348027.
Copy Download .nbib Format: NLM
Non-response to Cardiac Resynchronization Therapy.

Current heart failure reports

Naqvi SY, Jawaid A, Goldenberg I, Kutyifa V.
PMID: 30097910
Curr Heart Fail Rep. 2018 Oct;15(5):315-321. doi: 10.1007/s11897-018-0407-7.

PURPOSE OF REVIEW: Cardiac resynchronization therapy (CRT) is an effective treatment option for therapy-refractory mild to severe heart failure (HF) patients with reduced ejection fraction and left ventricular (LV) conduction delay. Multiple clinical trials have shown that CRT improves...

Cite
Naqvi SY, Jawaid A, Goldenberg I, et al. Non-response to Cardiac Resynchronization Therapy. Curr Heart Fail Rep. 2018;15(5):315-321doi: 10.1007/s11897-018-0407-7.
Naqvi, S. Y., Jawaid, A., Goldenberg, I., & Kutyifa, V. (2018). Non-response to Cardiac Resynchronization Therapy. Current heart failure reports, 15(5), 315-321. https://doi.org/10.1007/s11897-018-0407-7
Naqvi, Syed Yaseen, et al. "Non-response to Cardiac Resynchronization Therapy." Current heart failure reports vol. 15,5 (2018): 315-321. doi: https://doi.org/10.1007/s11897-018-0407-7
Naqvi SY, Jawaid A, Goldenberg I, Kutyifa V. Non-response to Cardiac Resynchronization Therapy. Curr Heart Fail Rep. 2018 Oct;15(5):315-321. doi: 10.1007/s11897-018-0407-7. PMID: 30097910.
Copy Download .nbib Format: NLM
[Cardio-renal syndrome in patients with heart failure: pathophysiology, epidemiology and clinical significance].

Kardiologia polska

Biegus J, Ponikowski P.
PMID: 22090234
Kardiol Pol. 2011;69(11):1181-8.

No abstract available.

Cite
Biegus J, Ponikowski P. Zespoły sercowo-nerkowe u chorych z niewydolnością serca: patofizjologia, epidemiologia, znaczenie kliniczne. [Cardio-renal syndrome in patients with heart failure: pathophysiology, epidemiology and clinical significance]. Kardiol Pol. 2011;69(11):1181-8
Biegus, J., & Ponikowski, P. (2011). Zespoły sercowo-nerkowe u chorych z niewydolnością serca: patofizjologia, epidemiologia, znaczenie kliniczne. [Cardio-renal syndrome in patients with heart failure: pathophysiology, epidemiology and clinical significance]. Kardiologia polska, 69(11), 1181-8.
Biegus, Jan, and Ponikowski, Piotr. "Zespoły sercowo-nerkowe u chorych z niewydolnością serca: patofizjologia, epidemiologia, znaczenie kliniczne." [Cardio-renal syndrome in patients with heart failure: pathophysiology, epidemiology and clinical significance]. Kardiologia polska vol. 69,11 (2011): 1181-8.
Biegus J, Ponikowski P. Zespoły sercowo-nerkowe u chorych z niewydolnością serca: patofizjologia, epidemiologia, znaczenie kliniczne. [Cardio-renal syndrome in patients with heart failure: pathophysiology, epidemiology and clinical significance]. Kardiol Pol. 2011;69(11):1181-8. Polish. PMID: 22090234.
Copy Download .nbib Format: NLM
Showing 35521 to 130 of 130 entries